From PET scan results to molecular biology data, it has long been known that increased glucose metabolism is a common
By Dr. Ted Lampidis Most medical researchers never live long enough to realize that what they have accomplished has contributed to humanity in the form of a life-saving procedure, medical device, drug, or vaccine. Perhaps
The following is a review of the literature and evidence supporting the anti-viral properties of 2-DG, lending further credence to
We have been developing 2-deoxy-D-glucose (2-DG), an analog of glucose, as a non-toxic anti-cancer agent and in an FDA-approved Phase
Since 2-DG became available in Germany in 2018, The Lampidis Cancer Foundation has been actively collaborating with participating doctors and
Combining non-toxic glycolytic inhibitors with non-toxic antibiotics Although it has long been known that the anti-oxidant properties of vitamin C may be linked to its purported anti-cancer properties, more recently the blockage of glucose uptake
In a recent publication titled 2-Deoxy-D-Glucose Inhibits Aggressive Triple-negative Breast Cancer Cells By Targeting Glycolysis And The Cancer Stem Cell
As reported in September, the Lampidis Cancer Foundation, along with the MCS Foundation for Life, has been actively collaborating with
An article published in the British journal Nature last week reports the anti-cancer activity of the naturally found sugar mannose.
Dr. Lampidis Collaborates on Groundbreaking 2-DG Clinical Trial in Germany We are delighted to announce today that the Lampidis Cancer